Annual Long Term Debt
$1.51 B
+$6.55 M+0.44%
December 31, 2024
Summary
- As of February 24, 2025, HALO annual long term debt is $1.51 billion, with the most recent change of +$6.55 million (+0.44%) on December 31, 2024.
- During the last 3 years, HALO annual long term debt has risen by +$718.54 million (+91.27%).
- HALO annual long term debt is now at all-time high.
Performance
HALO Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
N/A
December 31, 2024
Summary
- HALO quarterly long term debt is not available.
Performance
HALO Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
HALO Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.4% | - |
| 3 y3 years | +91.3% | - |
| 5 y5 years | +293.1% | - |
HALO Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +91.3% | ||
| 5 y | 5-year | at high | +293.1% | ||
| alltime | all time | at high | -100.0% |
Halozyme Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.51 B(+0.4%) | - |
| Sep 2024 | - | $1.50 B(+0.1%) |
| Jun 2024 | - | $1.50 B(+0.1%) |
| Mar 2024 | - | $1.50 B(+0.1%) |
| Dec 2023 | $1.50 B(+0.4%) | $1.50 B(+0.1%) |
| Sep 2023 | - | $1.50 B(+0.1%) |
| Jun 2023 | - | $1.50 B(+0.1%) |
| Mar 2023 | - | $1.49 B(+0.1%) |
| Dec 2022 | $1.49 B(+89.6%) | $1.49 B(+0.1%) |
| Sep 2022 | - | $1.49 B(+30.0%) |
| Jun 2022 | - | $1.15 B(+45.6%) |
| Mar 2022 | - | $788.10 M(+0.1%) |
| Dec 2021 | $787.25 M(+105.5%) | $787.25 M(+0.1%) |
| Sep 2021 | - | $786.45 M(+0.1%) |
| Jun 2021 | - | $785.57 M(+0.1%) |
| Mar 2021 | - | $784.73 M(+99.4%) |
| Sep 2020 | - | $393.63 M(+0.9%) |
| Jun 2020 | - | $390.08 M(+0.9%) |
| Mar 2020 | - | $386.57 M(+0.9%) |
| Dec 2019 | $383.05 M(+998.4%) | $383.05 M(+4015.2%) |
| Sep 2019 | - | $9.31 M(-33.9%) |
| Jun 2019 | - | $14.08 M(-24.9%) |
| Mar 2019 | - | $18.74 M(-46.3%) |
| Dec 2018 | $34.87 M | $34.87 M(-39.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $57.94 M(-26.7%) |
| Jun 2018 | - | $79.08 M(-23.0%) |
| Mar 2018 | - | $102.70 M(-17.9%) |
| Dec 2017 | $125.14 M(-37.2%) | $125.14 M(-13.9%) |
| Sep 2017 | - | $145.42 M(-12.1%) |
| Jun 2017 | - | $165.52 M(-10.3%) |
| Mar 2017 | - | $184.43 M(-7.4%) |
| Dec 2016 | $199.23 M(+612.3%) | $199.23 M(-0.3%) |
| Sep 2016 | - | $199.80 M(-2.5%) |
| Jun 2016 | - | $204.85 M(+21.5%) |
| Mar 2016 | - | $168.60 M(+502.8%) |
| Dec 2015 | $27.97 M(-43.9%) | $27.97 M(-18.0%) |
| Sep 2015 | - | $34.09 M(-15.0%) |
| Jun 2015 | - | $40.10 M(-12.8%) |
| Mar 2015 | - | $45.98 M(-7.8%) |
| Dec 2014 | $49.86 M(+0.2%) | $49.86 M(+25.4%) |
| Sep 2014 | - | $39.76 M(-8.8%) |
| Jun 2014 | - | $43.61 M(-8.0%) |
| Mar 2014 | - | $47.39 M(-4.8%) |
| Dec 2013 | $49.77 M(+60.0%) | $49.77 M(+89.0%) |
| Sep 2013 | - | $26.33 M(-6.5%) |
| Jun 2013 | - | $28.18 M(-5.4%) |
| Mar 2013 | - | $29.77 M(-4.3%) |
| Dec 2012 | $31.11 M(>+9900.0%) | $31.11 M(>+9900.0%) |
| Dec 2011 | $0.00 | $0.00 |
FAQ
- What is Halozyme Therapeutics annual long term debt?
- What is the all time high annual long term debt for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual long term debt year-on-year change?
- What is the all time high quarterly long term debt for Halozyme Therapeutics?
What is Halozyme Therapeutics annual long term debt?
The current annual long term debt of HALO is $1.51 B
What is the all time high annual long term debt for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual long term debt is $1.51 B
What is Halozyme Therapeutics annual long term debt year-on-year change?
Over the past year, HALO annual long term debt has changed by +$6.55 M (+0.44%)
What is the all time high quarterly long term debt for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly long term debt is $1.50 B